National cancer clinical trials: Children have equal access; adolescents do not

作者: W BLEYER , H TEJEDA , S MURPHY , L ROBISON , J ROSS

DOI: 10.1016/S1054-139X(97)00110-9

关键词: EpidemiologyPediatric cancerDisadvantagedEthnic groupPublic healthIncidence (epidemiology)PediatricsClinical trialCancerMedicine

摘要: Purpose. To determine whether adolescents with cancer, who in comparison to younger patients have a higher cancer incidence and lower mortality reduction, equal access national clinical trials. Methods. The ethnic/racial distribution of 29, 859 subjects Results. Children's Cancer Group Pediatric Oncology had 134 (97.6%) the total study entries among 94% children Conclusions. pediatric cooperative groups allow majority American 75% are not being enrolled by any group sponsored National Institute. Thus, older disadvantaged respect trials, regardless their race or ethnicity.

参考文章(12)
Julie A. Ross, Richard K. Severson, Leslie L. Robison, Brad H. Pollock, Joseph P. Neglia, William G. Woods, G. Denman Hammond, Pediatric cancer in the United States. A preliminary report of a collaborative study of the childrens cancer group and the pediatric oncology group Cancer. ,vol. 71, pp. 3415- 3421 ,(1993) , 10.1002/1097-0142(19930515)71:10+<3415::AID-CNCR2820711747>3.0.CO;2-#
Gregory H. Reaman, Janet Bonfiglio, Mark Krailo, Cameron K. Tebbi, Sanford Leikin, Robert Ettinger, Lonnie K. Zeltzer, James B. Nachman, Gaston K. Rivera, Albert Aboulafia, David S. Rosen, Cancer in Adolescents and Young Adults Cancer. ,vol. 71, pp. 3206- 3209 ,(1993) , 10.1002/1097-0142(19930515)71:10+<3206::AID-CNCR2820711706>3.0.CO;2-A
E L Lennox, C A Stiller, P H Jones, L M Wilson, Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. BMJ. ,vol. 2, pp. 567- 569 ,(1979) , 10.1136/BMJ.2.6190.567
James Nachman, Harland N Sather, Jonathan D Buckley, Paul S Gaynon, Peter G Steinherz, David G Tubergen, Beatrice C Lampkin, G Denman Hammond, None, Young adults 16-21 years of age at diagnosis entered on childrens cancer group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment Cancer. ,vol. 71, pp. 3377- 3385 ,(1993) , 10.1002/1097-0142(19930515)71:10+<3377::AID-CNCR2820711741>3.0.CO;2-8
H. A. Tejeda, S. B. Green, E. L. Trimble, L. Ford, J. L. High, R. S. Ungerleider, M. A. Friedman, O. W. Brawley, Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment Trials Journal of the National Cancer Institute. ,vol. 88, pp. 812- 816 ,(1996) , 10.1093/JNCI/88.12.812
James G. Gurney, Scott Davis, Richard K. Severson, Jei-Yin Fang, Julie A. Ross, Leslie L. Robison, Trends in cancer incidence among children in the U.S. Cancer. ,vol. 78, pp. 532- 541 ,(1996) , 10.1002/(SICI)1097-0142(19960801)78:3<532::AID-CNCR22>3.0.CO;2-Z
H. P. Wagner, I. Dingeldein-Bettler, W. Berchthold, A. Ridolfi Lüthy, A. Hirt, H. J. Plüss, D. Beck, M. Wyss, E. Signer, P. Imbach, A. Feldges, E. A. Bleher, J. Plaschkes, J. Briner, K. Leibundgut, N. Von Der Weid, Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients. Medical and Pediatric Oncology. ,vol. 24, pp. 281- 286 ,(1995) , 10.1002/MPO.2950240503
Sharon B. Murphy, The National Impact of Clinical Cooperative Group Trials for Pediatric Cancer Medical and Pediatric Oncology. ,vol. 24, pp. 279- 280 ,(1995) , 10.1002/MPO.2950240502